Global Nano Robotics Market is predicted to reach US$ 19.86 Billion with the aid of 2032, developing at a CAGR of 11.34% from 2024 to 2032. According to Renub Research, Nano Robotics Market turned into worth US$ 7.55 Billion in 2023.

Nanorobotics is a field of robotics that involves designing and controlling robots at the nanoscale. Nanorobots have precise properties that allow them to govern substances and carry out duties beyond the abilities of conventional robots. Advances in materials science, nanotechnology, and pc engineering have pushed the development of nanorobotics. Nanorobots have several promising medical programs, consisting of drug shipping, ailment diagnosis, and tissue restoration. They also can be utilized in environmental tracking and growing new materials.


Global Nano Robotics Market Trends

The upward incidence of chronic diseases and the need for particular and customized treatments: Non-communicable diseases (NCDs) are responsible for 74 percent of all global fatalities, causing 41 million deaths a year. Seventeen million individuals die from a continual ailment before attaining the age of 70, and the bulk of those deaths arise in low- and middle-income economies. Nanorobots are increasingly in demand inside the healthcare industry to provide unique and customized remedies for persistent diseases.

Advancements in nanotechnology: Nanorobots have the capability to revolutionize healthcare. They can deliver medicines to specific cells or locations, carry out minimally invasive surgeries, invest in unique tissue restoration, and carry out molecular diagnostics. In February 2021, TESCAN released a nanomanipulator designed to assist in TEM sample lift-out and micro- and nanoscale manipulation below room temperature and cryo situations.

Focus on Regenerative Medicine: The nanorobotics marketplace is predicted to grow due to the focus on regenerative medication. This field makes a specialty of developing treatments to restore, update, or regenerate damaged cells, tissues, and organs. Nanorobotics may be harnessed to improve the development of regenerative remedies, offering promising possibilities for tissue restoration and regeneration. The global financing of regenerative medicinal drugs has increased to USD 22.7 billion in 2021 from USD 19.9 billion. This financing is being used to aid 2,406 products that are under investigation. The rising consciousness of regenerative medication is driving the growth of the nanorobotics marketplace.

Governments, private institutions, and company investment: Innovation thrives on financial support, empowering researchers to explore new possibilities and commercial applications. A prime example is Nanobots Therapeutics, a technology company that recently closed a Pre-Seed funding round of ?478,000 (US$ 504,185) to develop and commercialize their MotionTx platform. The startup specializes in creating biocompatible nanorobots that deliver drugs to difficult-to-treat tumors more efficiently and safely than current therapies.

NanobotsTherapeutics was selected as the third investment in the fifth edition of Banco Sabadell’s BStartup Health program received 127 startup applications. Google and GlaxoSmithKline have partnered to form a nanobot powerhouse that will showcase the significance of nanorobotics in the future. French startup Eligo has raised US$ 27.4 Million to put protein-based nanobots in the bowels and is now moving clinical programs into humans.


Asia Pacific Nano Robotics Market

The nanorobots market is anticipated to witness significant growth in the Asia-Pacific region owing to the swift progress in nanotechnology and the availability of research and development prospects in emerging economies such as India and China. The governments of countries like Japan and China exhibit active involvement in research and development activities, promoting innovation and facilitating the acceptance of nanorobotic technologies. The potential of nanoscale industrial robots in China for manufacturing and producing nanomaterials with precision and accuracy is discussed. In Japan, JEOL’s InTouchScope SEM JSM-IT200 series has been launched. It comes in four configurations, each equipped with different capabilities. SurfRider’s "HQ-Series" of budget-priced AFM probes and Asylum Research’s model suitable for nanomechanical imaging are also mentioned.


Global Nano Robotics Market Company News

The global nanorobotics market comprises key companies like Oxford Instruments, Thermo Fisher Scientific, Bruker Corporation, JEOL Ltd, Agilent Technologies, Inc., Ginkgo Bio Works, Park Systems, and Imina Technologies.

  • In February 2023, Ginkgo Bioworks and Bioweg entered into a partnership to enhance the manufacturing process of bacterial cellulose and create novel cellulose variations with improved performance for diverse markets.
  • JEOL Ltd. released the "JIB-PS500i" FIB-SEM system in February 2023. This system provides higher resolution and precision for morphological observation and elemental analysis of new materials due to their finer structure and increased complexity of operations.
  • Nanobots Therapeutics, a spin-off created by IBEC and ICREA, aims to develop and commercialize the MotionTx platform, which uses nanorobots with unique tumor penetration capabilities. The technology is expected to be ready by February 2023.
  • April 2022, Nanovery, a biotechnology research company, has recently secured over ?1.85 million in funding to support its mission of developing more accurate testing for chronic illnesses such as prostate cancer and liver disease. The company’s nanorobot platform can detect such infections, and its innovations can be applied to various sectors, including pre-clinical drug development, life sciences, agriculture bio, and food safety.
  • TESCAN Orsay Holding has released the TESCAN Nanomanipulator. This solution enables lift-out and micro- and nanoscale manipulation under room-temperature and cryo conditions on TESCAN SEM and FIB-SEM instruments. It was launched in February 2021.
  • Bionaut Labs announced in March 2021 that it had secured US$ 20 Million in funding in a financing round led by Khosla Ventures and Upfront Ventures. Bionaut Labs is developing nanorobots that can administer drugs to treat brain diseases.




Product Type – Global Nano Robotics Market breakup in 6 viewpoints:

1. Bio-Nanorobots
2. Nano-Surgery Robots
3. Magnetically Guided Nanorobots
4. Bacteria-Based Nanorobots
5. DNA-Based Nanorobots
6. Molecular Nanorobots


Application – Global Nano Robotics Market breakup in 5 viewpoints:

1. Nanomedicine
2. Biomedical
3. Drug Delivery
4. Medical Imaging
5. Others


Country – Global Nano Robotics Market breakup of 25 Countries Covered in the Report:

1. North America

1.1 United States
1.2 Canada

2. Europe

2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherlands
2.8 Turkey

3. Asia Pacific

3.1 China
3.2 Japan
3.3 India
3.4 South Korea
3.5 Thailand
3.6 Malaysia
3.7 Indonesia
3.8 Australia
3.9 New Zealand

4. Latin America

4.1 Brazil
4.2 Mexico
4.3 Argentina

5. Middle East & Africa

5.1 Saudi Arabia
5.2 UAE
5.3 South Africa


All the Key players have been covered from 3 Viewpoints:

  • Overview
  • Recent Development
  • Revenue Analysis




Company Analysis:

1. Oxford Instruments
2. Thermo Fisher Scientific
3. Bruker Corporation
4. JEOL Ltd
5. Agilent Technologies, Inc.
6. Ginkgo Bio Works
7. Park Systems
8. Imina Technologies